ROBERT CROWELL: Open Payments
NPI 1386110468 · HELENA, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,166 in 110 payments from 12 companies in 2025. Trend: 2023 $1,449 · 2024 $2,024 · 2025 $2,166
Food & beverage: $2,166
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 27 | $619 |
| Vanda Pharmaceuticals Inc. | 16 | $313 |
| Otsuka America Pharmaceutical, Inc. | 11 | $281 |
| ABBVIE INC. | 24 | $227 |
| Axsome Therapeutics, Inc. | 6 | $169 |
| E.R. Squibb & Sons, L.L.C. | 5 | $113 |
| Lundbeck LLC | 4 | $98 |
| Neurocrine BioSciences, Inc. | 4 | $90 |
| Alkermes, Inc. | 4 | $85 |
| Janssen Pharmaceuticals, Inc | 4 | $80 |
Products named: CAPLYTA, REXULTI, FANAPT, VRAYLAR, Auvelity, COBENFY, INGREZZA, SPRAVATO.
Industry payments across AL — which companies pay providers there.
